Skip To Main Content
Yingjie Yu on Muck Rack

Yingjie Yu

As seen in: Nature, Wiley Online Library, PLOS ONE, ScienceDaily, MDPI, Science Magazine, Royal Society of Chemistry, Emerald Publishing, Optica, Chemistry World
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yingjie

Contact Yingjie, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

A biodegradable piezoelectric vertebral implant for programmable electro-neuromodulation in spinal cord injury

|
By Irene Varela-Martínez, Zhenlan Yao, Da-Hyun Kim, Penghao Liu, Xinyu Wang, Yanchun Liu, Zhuofan Xu, Yana He, Yongchang Lu, Liguo Ye, Wenjing Wu, Zan Chen, Yushu Wang, Fengyu Zhang, Xiaoping Yang, Yingjie Yu, Qing Cai, Wanru Duan
| Science Magazine Verified
Abstract INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS Acknowledgments Supplementary Materials REFERENCES Information & Authors Metrics & Citations View Options References Figures Tables Media Share Abstract Spinal cord stimulation has emerged as a promising therapeutic strategy for spinal cord injury (SCI), yet conventional electronic implants remain limited by surgical risk and long-term safety concerns.
Open in Who Shared Issue with article?

Incorporation of Novel Synthetic Glycolipids in Liposomal Nanoparticles Affects Opsonization and In Vivo Clearance

|
By Yingjie Yu, Xuehan Li, Yu Gao
| pericles.pericles-prod.literatumonline.com
Yingjie Yu and Xuehan Li contributed equally to this work. Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request. Supporting Information Filename Description anie72114-sup-0001-SuppMat.docx45 MB Supporting File 1: anie72114-sup-0001-SuppMat.Docx.
Open in Who Shared Issue with article?

Chidamide synergizes with cisplatin-etoposide to trigger pyroptosis and anti-tumor immunity in diffuse large B-cell lymphoma

|
By Jianbo Wu, Yingying Ye, Danyang Ran, Xing Wang, Hanwen Zhu, Hanmei Zhang, Fuqing Meng, Yalong Song, Zhiwei Li, Xiaoyuan Zhang, Yixin Qian, Hanrong Li, Xiaowei Tong, Bowen Sun, Xinya Li, Weimin Zhang, Huajun Wu, Yingjie Yu, Yunkun Dang, Fan Lai, Lijuan Deng, Yuqin Song, Jun Zhu, Yan Xie, Mi Deng, Peihuang Wu
| Nature Verified
Abstract Diffuse large B-cell lymphoma (DLBCL) is an aggressive malignancy where many patients relapse after standard therapy, necessitating novel approaches. Pyroptosis is an inflammatory cell death that can stimulate antitumor immunity. Histone deacetylases are frequently overexpressed in DLBCL and contribute to immune evasion. This study investigates whether combining the HDAC inhibitor chidamide with cisplatin and etoposide induces pyroptosis and enhances antitumor immune responses.
Open in Who Shared Issue with article?
See all 46 licensed articles (49 Total)